Medicines Agency gives go-ahead for new Pfizer logistic concept in Denmark
Customised solution: the trans-o-flex Logistics Group supplies all Danish hospitals and wholesalers within 24 hours after collecting the goods in Germany
trans-o-flex Logistik-Service GmbH, a company of the trans-o-flex logistics Group, has developed a new concept for the American pharmaceutical company Pfizer with respect to the distribution of Pfizer products in Denmark. The implementation of the concept has already been successfully initiated. As an important prerequisite, the Danish Medicines Agency had to authorise 3D Logistik A/S in Kolding, trans-o-flex’s partner in this project, to collect and distribute pharmaceutical products. Danish law does not permit the distribution of pharmaceutical products without licence. On the contrary: with respect to importing pharmaceuticals, it is legally prescribed that each product of a shipment is compared with the relevant release certificates at batch level.
This so-called “entry check”, which is carried out every morning in Kolding, is backed by the Pfizer warehouse management system that has been installed on site. Once the entry check has led to a positive outcome, the procedure to ensure the nation-wide and, thus, same-day delivery of the shipments in Denmark is immediately initiated. In order to control and document all shipment processes, the Danish logistics partner has been connected to the trans-o-flex operating core system. This increases the transparency and facilitates the shipment tracking procedure because all steps during the entire transport chain are carried out by one and the same IT system. trans-o-flex collects the shipments in Pfizer’s distribution centre in Karlsruhe, which is also used to supply the markets in Germany, Austria and the Netherlands.
In the past, Pfizer had based its Denmark activities on a domestic solution with a local logistic company. However, in order to centralise the warehouse logistics in Karlsruhe, they looked for a partner who, despite and in compliance with the strict Danish laws and provisions, was able to deliver the shipments all over Denmark on the next working day. Here was where trans-o-flex, with an individual logistic solution as well as its specific pharmaceutical know-how and established distribution structures, could score. In co-operation with Pfizer’s logistics managers, the customised distribution solution for Denmark was developed and implemented within just twelve weeks.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

The dangerous dual role of the immune system in COVID-19 - Immune cells occasionally overshoot the mark and, due to their excessive reaction, sometimes cause greater damage than the virus itself
Valneva Announces Start of Phase II Clinical Trial of its Clostridium difficile vaccine candidate

SRI spins off AI-powered drug discovery platform Synfini, Inc. - Synfini to commercialize and scale automated compound testing for rapid drug production
Argonne, University of Chicago scientists develop targeted cancer treatment using nanomaterials - Nano-bio material kills cancer cells, leaves healthy cells in unharmed

Blood tests could predict survival odds for patients with metastatic cancer - By measuring the proportion of DNA in the bloodstream that comes from a tumor, liquid biopsies may be able to guide treatment discussions
Complex inhalers prevent patients from taking medicine
